Factor | Screen-detected (n = 4747) | Symptom-detected (n = 7280) | ||||||
---|---|---|---|---|---|---|---|---|
Quantile 50Â % | Quantile 90Â % | Quantile 50Â % | Quantile 90Â % | |||||
Days | P-value | Days | P-value | Days | P-value | Days | P-value | |
Intercept | Â | Â | ||||||
 | 4.0 | ** | 38.7 | ** | 20.4 | ** | 108.5 | ** |
Demographic factors | Â | |||||||
Age | Â | Â | ||||||
 50–69 (Ref.) |  |  | ||||||
 39- | NA | NA | NA | NA | −1.0 | 0.29 | −9.7 | 0.05 |
 40–49 | 0 | 1.00 | 14 | * | −0.8 | 0.19 | 1.6 | 0.72 |
 70–74 | 0 | 1.00 | 4.9 | 0.26 | 1.2 | 0.42 | −1.2 | 0.88 |
 75+ | 1.0 | 0.19 | −4.9 | 0.19 | −1.4 | 0.07 | −19.7 | ** |
Neighborhood income quintile | Â | |||||||
  > 80 % (Ref.) |  |  | ||||||
 60 % ~ 80 % | 0 | 1.00 | −3.3 | 0.52 | 1.6 | 0.06 | −7.4 | 0.16 |
 40–60 % | 1.0 | 0.17 | −6.9 | 0.15 | 0.6 | 0.44 | −3.9 | 0.48 |
 20 % ~ 40 % | 2.0 | ** | −2.9 | 0.54 | 1.8 | * | −7.4 | 0.20 |
  < 20 % | 2.0 | ** | −8.4 | 0.11 | 1.4 | 0.11 | −9.4 | 0.10 |
 Missing | 16.0 | 0.19 | 63.0 | 0.52 | 5.4 | 0.42 | −11.7 | 0.78 |
Clinical factors | Â | Â | ||||||
Stage | Â | Â | ||||||
I (Ref.) | Â | Â | ||||||
 In Situ | 11.0 | ** | 28.0 | ** | 24.8 | ** | 49.2 | ** |
 II | 0.0 | 1.00 | 9.3 | * | −6.4 | ** | −36.7 | ** |
 III | 0.0 | 1.00 | 60.8 | ** | −7.0 | ** | −29.8 | ** |
 IV | −3.0 | 0.27 | 16.0 | 0.42 | −12.2 | ** | −37.7 | ** |
 Missing | 16.0 | ** | 37.4 | 0.16 | −5.6 | * | −1.5 | 0.87 |
Charlson comorbidity index | Â | |||||||
 0/1 (Ref.) |  |  | ||||||
  > =2 | 1.0 | 0.22 | −3.1 | 0.56 | −0.8 | 0.50 | 7.3 | 0.11 |
Healthcare factors | Â | |||||||
Regional Health Authority | Â | |||||||
6 (Ref.) | Â | Â | ||||||
 1 | 20.0 | ** | 37.5 | ** | 7.8 | ** | 16.3 | 0.07 |
 2 | 30.0 | ** | 50.2 | ** | 12.6 | ** | 30.5 | ** |
 3 | 16.0 | ** | 18.9 | ** | 7.4 | ** | 5.7 | 0.20 |
 4 | 19.0 | ** | 19.3 | * | 6.0 | ** | −2.5 | 0.71 |
 5 | 10.0 | ** | 21.4 | 0.12 | 2.8 | 0.17 | 4.7 | 0.70 |
 7 | 6.0 | * | 9.6 | 0.22 | 1.2 | 0.47 | −21.5 | * |
 8 | 22.0 | ** | 118.8 | ** | −3.4 | 0.06 | −9.3 | 0.54 |
 9 | 21.0 | * | 6.4 | 0.97 | −3.0 | 0.27 | −17.7 | * |
Time Period | Â | Â | ||||||
 2004–2006 (Ref.) |  |  | ||||||
 2007–2010 | 1.0 | * | 5.9 | 0.06 | 0.2 | 0.70 | 6.1 | 0.06 |
Usual Provider Continuity | Â | Â | Â | Â | Â | Â | Â | |
 High continuity (>0.75, Ref.) |  |  |  |  |  |  |  | |
 Low continuity (<=0.75) | −0.0 | 1.00 | 5.4 | 0.12 | 0.4 | 0.50 | 2.9 | 0.46 |
 Minimum doctor visits | −1.0 | 0.26 | −2.77 | 0.62 | −2.0 | * | −19.2 | ** |
Community Size and Metropolitan Influence Zone | Â | |||||||
 Urban (Ref.) |  |  | ||||||
 Rural | 3.0 | * | −2.3 | 0.66 | −1.2 | 0.20 | 1.7 | 0.75 |